Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q2 2018 · 10-Q
Revenue$7.77B$7.77B+17.0% vs Q2 2017 Net Income$733.00M$733.00M+159.0% vs Q2 2017 EPS Diluted$0.41$0.41+156.2% vs Q2 2017 Gross Profit$3,923,000,000+28.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,244,000,000−7.9% Free Cash Flowderived$946,000,000−13.7% Margins · derivedGross margin50.5%+4.5 pt vs Q2 2017
Operating margin11.4%+5.5 pt vs Q2 2017
Net margin9.4%+5.2 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 1, 2018 · 32 d after period end